<<
>>

Meat and Milk Withdrawal Times

Relatively few studies have been conducted to determine drug metabolism and excretion in goats. Label informa­tion specifically for goats also is rarely available in the United States, because few drugs are approved by the Food and Drug Administration Center for Veterinary Medicine

Table A.1 Drugdosagesusedingoats.

bgcolor=white>Oxalate poisoning
Drug

Acepromazine

Dose

0.2 mg/kg IM

Indication

Tetanus

Chapter

5

Acepromazine 0.05-0.10 mg/kg IV Preanesthetic sedation 17
Acepromazine 0.3 mg/kg IV Sedation for bronchoalveolar lavage 9
Acetic acid 5% (vinegar) 0.5-1 l PO Urea toxicosis 19
Activated charcoal 0.75-2 g/kg PO Ethylene glycol poisoning 12
Activated charcoal 1 g/kg PO Organophosphate toxicosis, chlorinated hydrocarbon toxicosis 5
Albendazole 20 mg/kg PO divided into 2 doses of 10 mg/ kg at 12 h Gastrointestinal strongyles 10
Albendazole 10-15 mg/kg PO Tapeworms, liver flukes 10, 11
Alphaxalone 4.5 mg/kg slowly IV Short-term anesthesia 18
Ammonium chloride 200-300 mg/kg/day Urinary acidification 12
Ammonium chloride 0.5-1% of diet DM Urolithiasis prevention 12
Ammonium tetrathiomolybdate 100 mg PO SID for up to 3 wk in conjunction with 1 g sodium sulfate PO SID Copper toxicosis 7
Amoxicillin One commercial bovine mastitis tube every

12-24 h, two or three treatments

Mastitis 14
Ampicillin 5-10 mg/kg IM BID Bacterial pneumonia 9
Ampicillin 15 mg/kg SC TID Prevention of cystitis post surgically 12
Ampicillin sodium 10-50 mg/kg IV or IM QID Meningo-encephalitis 5
Amprolium 25-50 mg/kg PO SID for 5 d Coccidiosis 10
Aspirin 100 mg/kg PO BID in goats with a developed rumen and taper down to lowest dose that maintains comfort Joint pain (CAE), laminitis, meningitis adjunct 4, 5
Atipamezole 0.08-0.1 mg/kg slowly IV Reversal of medetomidine 17
Atipamezole 0.125-0.175 mg/kg, half slowly IV and half IM Reversal of xylazine 17
Atropine sulfate 0.6-1 mg/kg SC or IM, repeat as needed Organophosphate poisoning 5
Atropine 0.08 mg/kg IM Reduce salivation for devocalization 9
Buparvaquone 2.5 mg/kg IM once Theileriosis 7
Bupivacaine Up to 2 mg/kg in local block, with dexmedetomidine Disbudding 18
Butorphanol 0.2 m/kg IM Postsurgical analgesia 17
Calcium borogluconate 23% 50-100 mL SC 12
Calcium chloride 40 mg/kg in each testis Chemical castration 13
Calcium sodium versenate 110 mg/kg IV divided into two treatments

6 h apart for 3-5 d

Lead poisoning 5
Ceftiofur 1.1-2.2 mg/kg/d IM Bacterial pneumonia 9
Charcoal, activated 1 g/kg PO Chlorinated hydrocarbon toxicosis 5
Chloramphenicol Do not use in USA

10 mg/kg IV BID where permitted

Forbidden in USA

Salmonellosis

10
Cloprostenol 0.125-0.250 mg IM Luteolysis, correction of hydrometra 13
Closantel 10-20 mg/kg PO (risk of blindness with overdose) Liver flukes 11
Closantel 7.5 mg/kg Haemonchus 10
Clorsulon 7 mg/kg PO Liver flukes 11

bgcolor=white>Louse control
Drug Dose Indication Chapter
Clostridium perfringens C and D antitoxin 5 mL SC Prophylaxis of enterotoxemia 10
C.
perfringens C and D antitoxin
15-20 mL IV, repeat every 3-4 h Treatment of enterotoxemia 10
Colostrum 20% of bw PO over first 24 h Failure of transfer of passive immunity 19
Danofloxacin Do not use in USA Forbidden in USA
Danofloxacin 6 mg/kg SC, repeated in 48 h Mycoplasmosis 4
Decoquinate 0.5-1 mg/kg/d PO in feed, for at least 28 d Coccidiosis prevention 10
Decoquinate 2.5 mg/kg/d PO Cryptosporidiosis. This dose forbidden in USA 10
Decoquinate 2 mg/kg/d PO Toxoplasmosis prevention This dose forbidden in USA 13
Detomidine 0.01-0.02 mg/kg IM Moderate sedation 17
Dexamethasone 0.1 mg/kg/d IV Adjunct-listeriosis 5
Dexamethasone 1-2 mg/kg IM or IV Cerebral edema from polio-encephalomalacia 5
Dexamethasone 20-25 mg SC or IM Induction of parturition 13
Dexamethasone 0.44 mg/k IM once Toxic mastitis 14
Dextrose See Glucose
Diazepam 0.5-1.5 mg/kg IV Convulsions, tetanus 5
Diazepam 0.1-0.5 mg/kg IV Urolithiasis, to relax urethra 12
Diazepam 0.5 mg/kg IV Preanesthetic sedation 17
Diethylcarbamazine 40-60 mg/kg/d PO 1-6 d Setariasis 5
Diminazene aceturate 3.5 mg/kg IM once Trypanosomosis 7
Diminazene aceturate 3.0 mg/kg IM SID 1 or 2 d Babesiosis 7
Dioctyl sodium sulfosuccinate (DSS) 15-30 mL PO Bloat 10
Doxapram HCl 1-1.5 mg/kg IV or sublingually Resuscitation of neonate 13
Enrofloxacin Do not use in USA Forbidden in USA
Epinephrine 0.02-0.03 mg/kg IV Anaphylaxis 9, 10
Epinephrine 1 : 1000 1 mL IM Uterine relaxation for obstetric manipulation 13
Eprinomectin 1 mg/kg topical Gastrointestinal strongyles 10
Eprinomectin 0.4 mg/kg PO Gastrointestinal strongyles 10
Eprinomectin 0.5-1.0 mg/kg topical Muellerius 9
Equine chorionic gonadotropin (PMSG) 400-750 IU IM 48 h before progestogen withdrawal Induction of estrus out of season 13
Fenbendazole 10 mg/kg PO Dictyocaulus, gastrointestinal strongyles 9, 10
Fenbendazole 15 mg/kg Tapeworms 10
Fenbendazole 15-30 mg/kg PO Muellerius 9
Fenbendazole 50 mg/kg/d for 5 d PO Cerebrospinal nematodiasis 5
Florfenicol 40 mg/kg SC every 1-2 d Bacterial pneumonia 9
Flumethrin 1 mg/kg topical pour-on 2
Drug Dose Indication Chapter
Flunixin meglumine 1 mg/kg/d IV, IM, or PO Laminitis 4
Flunixin meglumine 1.1-2.2 mg/kg SID or BID IV or PO Muscle trauma (predation or post surgically) 4, 12
Flunixin meglumine 1.1 mg/kg IV BID Anti-inflammatory, pain relief 12, 13, 17
Flunixin meglumine 2.2 mg/kg IV, IM, or PO Pain relief with pneumonia 9
Flunixin meglumine 1-2 mg/kg IV or IM BID Meningo-encephalitis 5
Furosemide 1 mg/kg IV Cerebral edema 5
Furosemide 5 mg/kg IV Lung edema from anaphylaxis 9
Furosemide 50-100 mg IM or IV Udder edema 14
Gentamicin 3 mg/kg IV or IM TID Meningo-encephalitis 5
Gentamicin 1 mg/kg IM or SC TID Salmonellosis 10
Glucose 25-50 g IV as 5% or 10% solution Pregnancy toxemia, ketosis 19
Glucose 20% solution 25-50 mL IP Hypoglycemia in neonate 19
Griseofulvin 25 mg/kg/d PO for 3 wk Ringworm, rarely justified 2
Halofuginone lactate 0.1 mg/kg PO SID for 7 d Narrow margin of safety Cryptosporidiosis 10
Hyoscine plus metoclopramide plus vitamin E/selenium compound 0.3 mg/kg plus 0.5 mg/kg plus 0.l mg/kg IM once Abomasal bloat in young kids 10
Imidocarb dipropionate 1-2 mg/kg once Babesiosis 7
Isometamidium chloride 0.5-1.0 mg/kg IM Trypanosomosis prophylaxis 7
Ivermectin 0.5-20 mg/100 kg SC Warbles 2
Ivermectin 0.2-0.4 mg/kg SC, repeat in 2 and 4 wk Sarcoptic mange 2
Ivermectin 0.2 mg/kg PO Nose bots 9
Ivermectin 0.4 mg/kg PO Gastrointestinal strongyles 10
Ivermectin, adjunct to fenbendazole 0.2 mg/kg/d SC for 5 d Cerebrospinal nematodiasis 5
Kanamycin 5 mg/kg IM or SC TID Salmonellosis 10
Ketamine 6 mg/kg IV or 11 mg/kg IM General anesthesia 17
Ketoprofen 3 mg/kg IV or IM SID Postsurgical analgesia 17
Lasalocid 20-30 g/ton of feed Coccidiosis prevention 10
Levamisole 12 mg/kg PO Gastrointestinal strongyles 10
Levamisole 7.5 mg/kg PO or SC Dictyocaulus 9
Lidocaine Up to 7 mg/kg IM or SC Local analgesia 17, 18
Lidocaine 2% 2-4 mL Caudal epidural 17
Lincomycin/spectinomycin 5 mg/kg/d lincomycin +10 mg/kg/d spectinomycin IM for 3 d Mycoplasmosis (contagious agalactia) 4
Magnesium hydroxide 50 g PO (adult goat) Rumen acidosis 19
Medetomidine 0.005 mg/kg IV or 0.015 mg/kg IM Deep sedation 17
Melengestrol acetate (MGA) 0.125 mg/head BID PO for 10-14 d, followed by a prostaglandin IM Estrus synchronization in season (not permitted in USA) 13
Meloxicam 1 mg/kg SID PO Joint pain (CAE), muscle trauma (predation), other pain relief 4, 9, 13
Drug Dose Indication Chapter
Meloxicam Loading dose of 2 mg/kg; daily dose of 1 mg/kg until pain is controlled; then maintenance dose of 0.5-1 mg/kg every other day Laminitis 4
Methocarbamol 22 mg/kg IV Muscle relaxant (tetanus) 5
Methylene blue 1% 4-15 mg/kg IV Nitrate poisoning 9
Midazolam 0.4 mg/kg IV Preanesthetic sedation 17
Monensin 15-20 g/ton of feed Coccidiosis prevention 10
Morantel citrate 6 mg base/kg PO Paramphistomes 10
Morantel tartrate 10 mg/kg PO Gastrointestinal strongyles 10
Morphine 0.1 mg/kg IV Epidural block, dehorning analgesia 17, 18
Moxalactam 50 mg/kg IV BID-QID Meningo-encephalitis 5
Moxidectin 0.4 mg/kg PO Gastrointestinal strongyles 10
Moxidectin 0.5-1 mg/kg topical, repeat in 2 and 4 wk Sarcoptic mange 2
Niacin 1 g/animal/d IM or PO Pregnancy toxemia prevention and treatment 19
Niclosamide 50 mg/kg PO Tapeworms 10
Oxfendazole 30 mg/kg PO twice a week for 4 wk Echinococcosis 9
Oxytetracycline 10 mg/kg IV BID at least 3 d Listeriosis 5
Oxytetracycline 10 mg/kg IV once Tick-borne fever 7
Oxytetracycline 10 mg/kg IM or SC SID for 1 or 2 d Anaplasmosis 7
Oxytetracycline 15 mg/kg/d SC at least 5 d Mycoplasmosis 4
Oxytetracycline 5 mg/kg/d IV for 5 d (combined with intramammary therapy) Gangrenous mastitis 14
Oxytetracycline 20 mg/kg SC SID Actinomycosis 3
Oxytetracycline, long-acting 20 mg/kg SC or IM once Dermatophilosis, foot rot or foot scald, infectious keratoconjunctivitis, heartwater 2, 4, 6, 8
Oxytetracycline, long-acting 20 mg/kg SC or IM every 3 d Chlamydiosis, other abortion diseases 13
Oxytocin 5 IU IM or SC BID-TID Retained placenta, milk letdown 13
Oxytocin 50 IU IM BID for 4 d Correction of hydrometra 13
Paromomycin 100 mg/kg/d PO Cryptosporidiosis 10
Penicillamine 50 mg/kg/d PO for 7 d Copper toxicosis 7
Penicillin G, procaine 20 000 IU/kg/d IM for 7-14 d Staphylococcal dermatitis 2
Penicillin G, procaine 20 000-40 000 IU/kg/d IM Bacterial pneumonia 9
Penicillin G, procaine 22 000 IU/kg IM BID Prevention of cystitis post surgically 10
Penicillin G, procaine 25 000 IU/kg IM BID Tetanus 5
Penicillin G, procaine 44 000 IU/kg SID for 2 d Anthrax 7
Penicillin G, sodium 40 000 IU/kg IV QID followed by penicillin G procaine 20 000 IU/kg IM BID Listeriosis 5
Penicillin G, sodium 20 000-40 000 IU/kg IV or IM QID Meningo-encephalitis 5
Pentobarbital 30 mg/kg IV General anesthesia 17
Phenylbutazone 10 mg/kg/d PO Joint pain (CAE), laminitis 4
Drug Dose Indication Chapter
Poloxalene 100 mg/kg PO Bloat 10
Praziquantel 5-15 mg/kg PO Tapeworms 10, 11
Praziquantel 25-60 mg/kg PO Schistosomosis 8
Praziquantel 20 mg/kg PO SID for 2 d Eurytrema spp. pancreatic flukes 11
Prednisone, prednisolone 1 mg/kg IM BID for 7-10 d then taper Pemphigus foliaceus 2
Propofol 3-6 mg/kg IV slowly Anesthesia induction 17, 18
Proprionylpromazine 1 mg/kg IM Protrusion of the penis for examination 12
Propylene glycol 60 mL PO BID or TID Pregnancy toxemia, ketosis 19
Prostaglandin F2 alpha (dinoprost) 5-10 mg IM Luteolysis, correction of hydrometra 13
Pyrantel tartrate 25 mg/kg PO Gastrointestinal strongyles 10
Selenite, sodium 1 mg/18 kg SC once (follow label for sheep on selenium-vitamin E product) White muscle disease 4
Silver nitrate 5% solution few drops topically SID for 5 d Severe corneal ulcer 6
Sodium bicarbonate 20 g PO (adult goat) Rumen acidosis 19
Sodium bicarbonate 1.3% 125-200 mL IV Floppy kid disease 19
Sodium bicarbonate (powder) 2.5-3.0 g PO (0.5 tsp.
mixed with cold water)
Floppy kid disease 19
Sodium iodide 20 mg/kg IV or SC, weekly 5-7 wk Actinobacillosis (not documented in goats) 2
Sodium iodide 20 mg/kg IV or SC, weekly 5-7 wk Actinomycosis 3
Sodium iothalamate 2 mL/kg IV up to 28 kg bw. For heavier goats, reduce the total dose to 75% Radiographic contrast studies of the urinary tract 12
Sodium nitrite 22 mg/kg IV Cyanide poisoning 9
Sodium thiosulfate 660 mg/kg IV Cyanide poisoning 9
Spiramycin 50 mg/kg IM then 25 mg/kg/d Mycoplasmosis 4
Streptomycin 20 mg/kg/d 5-7 d Actinobacillosis (not documented in goats) 2
Streptomycin 10 mg/kg BID or TID Actinomycosis 3
Streptomycin 30 mg/kg/d IM at least 5 d Mycoplasmosis 4
Streptomycin 25 mg/kg IM single dose Leptospirosis 13
Sulfadimethoxine 75 mg/kg PO for 5 d Coccidiosis 10
Tetanus antitoxin 10 000-15 000 units IV BID Tetanus treatment 5
Tetanus antitoxin 250-300 IU SC/kid, 500 IU SC/adult Tetanus prophylaxis 18
Tetracycline 5 mg/kg IM or SC SID or BID Bacterial pneumonia 9
Tetracycline 0.5-1 g PO (single dose) Adjunct-rumen acidosis treatment 19
Thiamine 10 mg/kg IV, IM, or SC QID Polioencephalomalacia 5
Thiamine 300-500 mg IM or SC BID Adjunct-rumen acidosis 19
Thiamylal sodium 10 mg/kg IV Induction of anesthesia 17
Thiopental sodium 5-20 mg/kg IV Induction of anesthesia 17
Tiamulin 20 mg/kg/d IM at least 5 d; reported to be severely irritating at injection site; toxic myopathy Mycoplasmosis (CCPP) 4, 9

Drug Dose Indication Chapter
Tiamulin 10 mg/kg IM BID Mycoplasma mastitis 14
Tiletamine-Zolazepam 5.5 mg/kg IV General anesthesia 17
(Telazol®) 7.5-10 mg/kg IM
Tilmicosin Do not use May be fatal
Tolazoline 1.5 mg/kg IV Xylazine reversal 17
Triclabendazole 10 mg/kg PO Liver flukes 10
Schistosomosis 8
Trimethoprim-sulfonamide 16-24 mg/kg IV BID Meningo-encephalitis 5
Trimethoprim-sulfonamide 15 mg/kg IV BID (trimethoprim inactivated in rumen) Salmonellosis 10
Trimethoprim with 20 mg/kg Tick-borne fever 7
sulphamethylphenazole and 50 mg/kg
sulphadimidine 50 mg/kg

IV once

Tulathromycin 2.5 mg/kg SC Mycoplasma and Mannheimia pneumonia 9
Tylosin 10-20 mg/kg IM SID or BID Bacterial and mycoplasmal pneumonia 9
Tylosin 20 mg/kg/d IM at least 5 d Mycoplasmosis 4
Vancomycin Do not use in USA Forbidden in USA
Vitamin B12 0.01-0.3 mg IM weekly White liver disease 11
Xylazine 0.03-0.04 mg/kg IV Light sedation 17
Xylazine 0.05 mg/kg IV or 0.1 mg/kg IM Heavy sedation; combine with local anesthesia 17
Xylazine plus ketamine 0.22 mg/kg IM xylazine followed in 10 min by 11 mg/kg IM ketamine General anesthesia 17
Yohimbine 0.125 mg/kg IV Xylazine reversal 17
Zinc sulfate 1 g/d/adult goat PO or 10 mg/kg PO SID Zinc deficiency dermatopathy 2

BID, twice a day; bw, bodyweight; CAE, caprine arthritis encephalitis; d, day; DM, dry matter; h, hour; IM, intramuscular; IU, international units; IV, intravenous; IP, intraperitoneal; PO, orally; QID, four times a day; SC, subcutaneous; SID, once a day; TID, three times a day; tsp., teaspoon; wk, week.

for use in goats in the United States (Webb et al.

2004). In the United States, whenever a drug is administered in any way that differs from the label directions (to a different species, at a different dosage, by a different route), its use is said to be extralabel. Only a veterinarian can legally use a drug in an extralabel fashion, and then only in the pres­ence of a carefully defined veterinarian-client/patient relationship (U.S. Department of Health and Human Services 2005). The veterinarian is then responsible for specifying the time periods before meat or milk can be marketed, to ensure that no illegal drug residues occur. Practitioners working with goats are continually forced to extrapolate from other species (Lofstedt 1987; Riviere et al. 1997) or to select drug dosages or withdrawal periods on empirical bases.

A WT is the interval after dosing for all tissue concentra­tions of a drug or its metabolites to decrease to below a spe­cific concentration established as safe for human consumption by the regulatory agency involved (Riviere et al. 1998). For labeled drugs in the United States, the meat WT is the time required for 99% of treated animals to achieve drug concentrations in muscle, liver, and kidney below the established tolerance concentration (Riviere et al. 1998). The labeled WT takes into account slight errors in dosing and individual differences in clearance rates. The WT must be increased if a drug is given at a higher dosage than is on the label or to a severely diseased animal, as WTs are usually calculated in healthy animals. Typically, the WT is approximately 5-10 times the elimination half-life for the drug, and if the dose administered is doubled, the WT needs to be extended by one half-life, or 10-20%. If, on the other hand, the drug is given to an animal that is more severely compromised by its illness than those for which the drug is labeled, the elimination half-life increases and the WT becomes approximately 10 times the new half-life. A conservative approach is to begin the withdrawal period when the animal appears systemically healthy.

When the drug is given to an animal such as a goat, for which it is not labeled, the distribution and elimination parameters of the drug in that species must be taken into consideration when estimating a WT. Frequently, a smaller species (such as a goat) metabolizes and excretes a drug faster than a larger species of similar physiology (such as cattle), so a cattle WT is often adequate for goats if the same dose is administered (Riviere et al. 1997, 1998). Pharmacokinetic data from the world literature for goats and other species have been tabu­lated and published by the Food Animal Residue Avoidance Databank (FARAD; Craigmill et al. 2006).

American veterinarians should consult FARAD (http:// www.farad.org) for estimated meat and milk withdrawal periods for drugs not labeled for goats in the United States. Several helpful guides to withdrawal periods have been published (Baynes et al. 1997, 2000; Craigmill et al. 1997; Damian et al. 1997; Martin-Jimenez et al. 1997; Haskell et al. 2003, 2005; Gehring et al. 2005; Kukanich et al. 2005; Payne et al. 2006). A summary of some of the extralabel withdrawal intervals from these references, specifically for goats, is available at the FARAD website (http://www. farad.org/wdilookup/wdi_goats.html). Some estimated WTs from FARAD for tranquilizers and general anesthetic drugs are provided in Table 17.1.

In the United States, records must be kept for at least two years after extralabel drug use in goats (Anonymous 1998); some states require a longer period for maintaining records.

<< | >>
Source: Smith Mary C., Sherman David M.. Goat Medicine. 3rd edition. — Wiley-Blackwell,2023. — 976 p.. 2023

More on the topic Meat and Milk Withdrawal Times: